Table 2.
Prostate data | |||||
---|---|---|---|---|---|
Source | Benign | GP3 | GP4 | GP5 | Total |
Training partition | |||||
TMAZ | 2010 | 5992 | 4472 | 2766 | 15 240 |
SICAPv2 | 9432 | 6499 | 2250 | 2011 | 20 192 |
Total training | 11 442 | 12 491 | 6722 | 4777 | 35 432 |
Validation partition | |||||
TMAZ | 1350 | 1352 | 831 | 457 | 4927 |
SICAPv2 | 604 | 819 | 302 | 210 | 1935 |
Total validation | 1954 | 2171 | 1133 | 667 | 6862 |
Internal testing partition | |||||
TMAZ | 127 | 1602 | 2121 | 387 | 4237 |
SICAPv2 | 1033 | 3466 | 427 | 546 | 5427 |
Total internal testing | 1160 | 5068 | 2548 | 933 | 9709 |
External testing partition | |||||
Gleason challenge | 1080 | 2431 | 3649 | 100 | 7260 |
Diagset | 8783 | 1243 | 4334 | 696 | 15 056 |
Valme | 13 652 | 3026 | 5510 | 800 | 22 988 |
PANDA | 10 189 | 20 000 | 20 000 | 8014 | 58 203 |
Total external testing | 33 704 | 26 700 | 33 493 | 9610 | 103 507 |